Literature DB >> 19070659

Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.

Heather L Watt1, Geetanjali D Kharmate, Ujendra Kumar.   

Abstract

The role of somatostatin (SST) and epidermal growth factor (EGF) in breast cancer is undisputed; however, the molecular mechanisms underlying their antiproliferative or proliferative effects are not well understood. We initially confirmed that breast tumour tissues express all five somatostatin receptors (SSTR1-5) and four epidermal growth factor receptors (ErbB1-4). Subsequently, to gain insight into the function of SSTRs and ErbBs in oestrogen receptor (ER)-positive (MCF-7) or ERalpha-negative (MDA-MB-231) breast cancer cells, we defined SSTR1, SSTR5 and ErbB1 mRNA and protein expression in these two tumour cell lines. Consistent with previous studies showing SSTR1/SSTR5 heterodimerization and having seen cell-specific and ligand-selective alterations in receptor expression, we next elucidated whether SSTR1 and SSTR5 functionally interact with ErbB1 using pbFRET analysis. We subsequently determined the effects of SST and EGF either alone, or in combination, on selected downstream signalling molecules such as erk1/2, p38 and JNK. Here, we showed that both SST and EGF influenced erk1/2 phosphorylation and that SST modulated the effects of EGF in a cell-specific manner. We also demonstrated agonist-, time and cell-dependent regulation of p38 phosphorylation. We further investigated modulation of Grb2, SOS, Shc, SH-PTP1 and SH-PTP2. ErbB1 adaptor proteins known to play a role in MAPK activation, Shc, Grb2 and SOS, changed in an agonist- and cell-specific manner whereas, SH-PTP1 and SH-PTP2, adaptor proteins reported to interact with SSTRs, translocated from the cytosol to membrane in a cell-specific manner following SST and/or EGF treatment. Although several previous studies have shown crosstalk between RTKs and GPCRs, there are no reports describing SSTR (GPCR) modulation of ErbBs (RTK) in breast cancer. To the best of our knowledge, this is the first report describing crosstalk/interactions between SSTRs and ErbBs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070659     DOI: 10.1016/j.cellsig.2008.11.012

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  20 in total

1.  A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Marina Aloi; Federica Ferrari; Simone Frediani; Adriana Marcheggiano; Salvatore Cucchiara
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

2.  Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.

Authors:  Michael Rothenberg; Reetesh Pai; Kevin Stuart
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

3.  Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes.

Authors:  Claudia Casnici; Donatella Lattuada; Katia Crotta; Marcello Claudio Truzzi; Costantino Corradini; Francesca Ingegnoli; Noemi Tonna; Fabio Bianco; Ornella Marelli
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 4.  Cross-talk and modulation of signaling between somatostatin and growth factor receptors.

Authors:  Ujendra Kumar
Journal:  Endocrine       Date:  2011-08-26       Impact factor: 3.633

5.  Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting.

Authors:  H L Watt; Z Rachid; B J Jean-Claude
Journal:  J Neurooncol       Date:  2010-05-14       Impact factor: 4.130

6.  Upregulated expression of SSTR1 is involved in neuronal apoptosis and is coupled to the reduction of bcl-2 following intracerebral hemorrhage in adult rats.

Authors:  Damin Yuan; Jianhong Shen; Yaohua Yan; Xinmin Wu; Aihong Li; Aisong Guo; Yuanyuan Wu; Chengwei Duan; Jiabing Shen; Cuiying Tang; Dongmei Zhang; Yuhong Ji
Journal:  Cell Mol Neurobiol       Date:  2014-07-18       Impact factor: 5.046

7.  Natural history of adult-onset Ménétrier's disease: Report of a case with 9-year follow-up.

Authors:  Li-Shou Xiong; Ying-Ying Gong
Journal:  Exp Ther Med       Date:  2016-03-23       Impact factor: 2.447

8.  Receptor-Heteromer Investigation Technology and its application using BRET.

Authors:  Elizabeth K M Johnstone; Kevin D G Pfleger
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-22       Impact factor: 5.555

9.  Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis.

Authors:  Sajad A War; Ujendra Kumar
Journal:  J Mol Signal       Date:  2012-05-31

10.  Peptide receptor targeting in cancer: the somatostatin paradigm.

Authors:  Federica Barbieri; Adriana Bajetto; Alessandra Pattarozzi; Monica Gatti; Roberto Würth; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Pept       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.